LASP1 and prostate carcinoma: In addition, in prostate cancer, CKAP2, LASP1, BIRC5, WASF1, ASAP1 and RUNX2 mRNAs were recently identified as new miR-203 targets, suggesting that miR-203 could be a new prognostic marker and a therapeutic target in metastasis of prostate cancer [45].